NCT04494113 2026-03-18
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
1 trialsPhase EARLY_PHASE1 × Endometrial Serous Adenocarcinoma × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all